Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in IntangiblesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZNCF) Change in Acquisitions & Divestments (2019 - 2025)

Historic Change in Acquisitions & Divestments for Astrazeneca (AZNCF) over the last 7 years, with Q4 2025 value amounting to $9.0 million.

  • Astrazeneca's Change in Acquisitions & Divestments rose 12432.43% to $9.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $131.0 million, marking a year-over-year increase of 33666.67%. This contributed to the annual value of $131.0 million for FY2025, which is 33666.67% up from last year.
  • Astrazeneca's Change in Acquisitions & Divestments amounted to $9.0 million in Q4 2025, which was up 12432.43% from $7.0 million recorded in Q3 2025.
  • In the past 5 years, Astrazeneca's Change in Acquisitions & Divestments ranged from a high of $114.0 million in Q2 2025 and a low of -$57.0 million during Q1 2024
  • Its 5-year average for Change in Acquisitions & Divestments is $22.2 million, with a median of $9.0 million in 2023.
  • Per our database at Business Quant, Astrazeneca's Change in Acquisitions & Divestments soared by 77500.0% in 2023 and then plummeted by 73333.33% in 2024.
  • Astrazeneca's Change in Acquisitions & Divestments (Quarter) stood at -$24.0 million in 2021, then skyrocketed by 50.0% to -$12.0 million in 2022, then surged by 775.0% to $81.0 million in 2023, then tumbled by 145.68% to -$37.0 million in 2024, then soared by 124.32% to $9.0 million in 2025.
  • Its Change in Acquisitions & Divestments was $9.0 million in Q4 2025, compared to $7.0 million in Q3 2025 and $114.0 million in Q2 2025.